Effect of obesity on toxicity in women treated with adjuvant chemotherapy for early-stage breast cancer: a systematic review James CarrollMelinda ProtaniJennifer H. Martin Review 24 August 2012 Pages: 323 - 330
Role of epidermal growth factor receptor in breast cancer Hiroko MasudaDongwei ZhangNaoto T. Ueno Review 17 October 2012 Pages: 331 - 345
Mitochondria organelle transplantation: introduction of normal epithelial mitochondria into human cancer cells inhibits proliferation and increases drug sensitivity R. L. ElliottX. P. JiangJ. F. Head Review 19 October 2012 Pages: 347 - 354
Phase II trial of temsirolimus in patients with metastatic breast cancer Gini F. FlemingCynthia X. MaMatthew J. Ellis Clinical study 13 January 2012 Pages: 355 - 363
E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells Remco van HorssenAntoinette HollestelleTimo L. M. ten Hagen Preclinical study 29 September 2012 Pages: 365 - 377
mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo Yue ZhangSong XuXiaochun Bai Preclinical Study 29 September 2012 Pages: 379 - 388
Targeting the HOX/PBX dimer in breast cancer Richard MorganAngie BoxallHardev S. Pandha Preclinical Study 30 September 2012 Pages: 389 - 398
Investigation of elemene-induced reversal of tamoxifen resistance in MCF-7 cells through oestrogen receptor α (ERα) re-expression Bin ZhangXia ZhangYang Zhang Preclinical Study 30 September 2012 Pages: 399 - 406
Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer Julia Y. S. TsangYu-Hua HuangGary M. Tse Preclinical Study 30 September 2012 Pages: 407 - 417
TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcome Mohammed A. AleskandaranyOla H. NegmIan O. Ellis Preclinical Study 04 October 2012 Pages: 419 - 427
Zerumbone causes Bax- and Bak-mediated apoptosis in human breast cancer cells and inhibits orthotopic xenograft growth in vivo Anuradha SehrawatJulie A. ArlottiShivendra V. Singh Preclinical study 06 October 2012 Pages: 429 - 441
Bergapten induces ER depletion in breast cancer cells through SMAD4-mediated ubiquitination M. L. PannoF. GiordanoS. Andò Preclinical study 09 October 2012 Pages: 443 - 455
Surveillance of spontaneous breast cancer metastasis by TRAIL-expressing CD34+ cells in a xenograft model Anna RossiniMarta GiussaniAndrea Balsari Preclinical Study Open access 11 October 2012 Pages: 457 - 467
Efficacy of ‘radioguided occult lesion localisation’ (ROLL) versus ‘wire-guided localisation’ (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trial E. L. PostmaH. M. Verkooijenthe ROLL study group Clinical Trial 30 September 2012 Pages: 469 - 478
A randomized, controlled, double-blinded clinical trial of gabapentin 300 versus 900 mg versus placebo for anxiety symptoms in breast cancer survivors Jill E. LavigneCharles HecklerKaren Mustian Clinical Trial 02 October 2012 Pages: 479 - 486
A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study E. AlbaJ. I. ChaconJ. Albanell Clinical Trial 09 October 2012 Pages: 487 - 493
Tamoxifen adherence and its relationship to mortality in 116 men with breast cancer Shouping XuYumei YangDa Pang Clinical Trial 12 October 2012 Pages: 495 - 502
Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: follow-up analysis from the randomized ‘FIRST’ study John F. R. RobertsonJustin P. O. LindemannMatthew J. Ellis Clinical Trial 13 October 2012 Pages: 503 - 511
Identification of factors associated with cancer related fatigue syndrome in disease-free breast cancer patients after completing primary treatment Ollie MintonSusanna AlexanderPatrick Charles Stone Clinical Trial 14 October 2012 Pages: 513 - 520
Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review Dejana BraithwaiteMonika IzanoBette Caan Epidemiology 29 September 2012 Pages: 521 - 533
Influence of health insurance, hospital factors and physician volume on receipt of immediate post-mastectomy reconstruction in women with invasive and non-invasive breast cancer D. L. HershmanC. A. RichardsJ. D. Wright Epidemiology 29 September 2012 Pages: 535 - 545
Economic evaluation of radiotherapy for early breast cancer after breast-conserving surgery in a health resource-limited setting Yongrui BaiMing YeBin Wu Epidemiology 30 September 2012 Pages: 547 - 557
Breast cancer incidence by estrogen receptor status in Denmark from 1996 to 2007 J. BigaardC. StahlbergN. Kroman Epidemiology 30 September 2012 Pages: 559 - 564
A prognostic model of early breast cancer relapse after standard adjuvant therapy and comparison with metastatic disease on initial presentation Li ChenEdward RomondSuleiman Massarweh Epidemiology 04 October 2012 Pages: 565 - 572
Aromatase inhibitors in obese breast cancer patients are not associated with increased plasma estradiol levels Caroline DiorioJulie LemieuxÉric Vachon Epidemiology 06 October 2012 Pages: 573 - 579
Explaining age-related differences in depression following breast cancer diagnosis and treatment Nancy E. AvisBeverly LevineKimberly J. Van Zee Epidemiology 09 October 2012 Pages: 581 - 591
Associations between TCF7L2 polymorphisms and risk of breast cancer among Hispanic and non-Hispanic White women: the Breast Cancer Health Disparities Study Avonne E. ConnorRichard N. BaumgartnerMartha L. Slattery Epidemiology 21 October 2012 Pages: 593 - 602
Through the lens of culture: quality of life among Latina breast cancer survivors Kristi D. GravesRoxanne E. JensenJeanne Mandelblatt Epidemiology 21 October 2012 Pages: 603 - 613
Close association between genotypes of the Val158Met polymorphism and pain perception in pain patients besides breast cancer patients S. Kapoor Letter to the Editor 18 September 2012 Pages: 615 - 616
Comparing attendees with non-attendees in breast screening does not provide useful information about an effect on prognostic features or mortality K. J. JørgensenM. KalagerV. M. Fønnebø Letter to the Editor 26 September 2012 Pages: 617 - 620
Expression of co-stimulators CD28/B7-1 in peripheral blood of patients with breast cancer Jian GongWen PanYunping Sun Letter to the Editor 28 September 2012 Pages: 621 - 622
Erratum to: Comparison of relative versus absolute arm size change as criteria for quantifying breast cancer-related lymphedema: the flaws in current studies and need for universal methodology Marek AncukiewiczCynthia L. MillerAlphonse G. Taghian Erratum 28 September 2012 Pages: 623 - 623
Erratum to: RETRACTED ARTICLE: Late phase activation of nuclear transcription factor kappaB by doxorubicin is mediated by interleukin-8 and induction of apoptosis via FasL Charitha GangadharanMaikho ThohSunil Kumar Manna Erratum 21 October 2012 Pages: 625 - 625